Michael Chargualaf, Senior Director, Clinical Science Asset Lead at Daiichi Sankyo US, shared a post on LinkedIn:
“I’m happy to share that I’ve been promoted to Senior Director, Clinical Science Asset Lead at Daiichi Sankyo US!
I’m grateful for the opportunity to continue growing at Daiichi Sankyo. I look forward to advancing drug development with a shared commitment to rigorous science and meaningful impact for patients. Leading and developing people, while fostering strong cross functional collaboration is something I deeply value, and I’m excited to continue doing so in this role.
Thank you to the mentors, teammates, and leaders who have supported and challenged me along the way!”
More posts featuring Michael Chargualaf.